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Intr
One-fifth of patients admitted to Intensive Care Units suf-
fer from significant cardiac arrhythmias, contributing to a
major source of morbidity [1]. Since arrhythmias rarely
becomes obvious during admission, a close monitoring is
mandatory to ensure early therapeutic intervention if
necessary. However, the effects of disease pattern and
intensive care measures (e.g. sepsis, medication) on heart
rate and variability are poorly understood. Electrical
instability could be detected during repolarization shortly
before cardiac arrest with a high resolution ECG, not
recordable with a conventional ECG, even in patients
without prior heart pathologies [2].
Objectives
We analysed changes of beat-to-beat cardiac activity dur-
ing intensive care stay and therapeutic intervention (e.g.
antimycotic therapy) of double lung transplanted recipi-
ents with a high resolution electrocardiogram. Obtained
results may offer new insights in the development of
alterations in cardiac electrical activity of critical ill
patients.
Methods
At 1000 Hz sampling rate the cardiac electric activity of 45
double lung transplanted recipients on ICU were analysed
during their stay and inhalationtherapy with 50 mg of
Amphotericin B®. The electrodes were fixed on the pre-
pared skin for recording the leads I, II, III and reconstruct
pursuant to Einthoven´s equation aVR, aVL, aVF, obtain-
ing continuous ten-minute recordings (Lab SystemTh
Pro - Bard electrophysiology U.S.A.).
Results
Results obtained from 45 Amphotericin B® treatments
show irrespective of the prior QT range an increasing of
the QT-interval additionally up to 21 ms (p < 0,05)
from the beginning of the infusion. This variation was
observed for two minutes of therapy and returns with a
slow to their pre-value. Concerning QT prolongation
the beat-to-beat duration increases too. Other ECG data
remained unchanged during the time of treatment.
Conclusions
Haemodynamic alterations could be detected after the
onset of antimycotic treatment with Amphotericin® lung
transplantation recipients. With regard to comorbidities of
lung transplanted patients, it seems reasonable that
changes in cardiac electric activity based on heart lung
interactions in humans during their ICU stay and their
origin might be observed even earlier. In contrast even
minor circadian beat to beat variations might precede the
occurrence of potentially life threatening arrhythmias.
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